There's Still a Lot Of Work to Do
Bloomberg Businessweek|February 08, 021
With the emergence of coronavirus variants, vaccine makers are racing to develop booster shots

Just two months ago, the prospects for beating the novel coronavirus with highly effective vaccines couldn’t have seemed better. Shots from Moderna and the Pfizer-BioNTech partnership proved more than 90% effective in preventing Covid-19 symptoms in massive trials, surpassing the most optimistic forecasts. An end to the pandemic appeared imminent.

Yet pharma companies now suddenly face a daunting challenge that few anticipated we’d see so soon: an onslaught of fast-spreading and potentially dangerous mutations of the virus. So even as they ramp up production in the early stages of a massive rollout, drugmakers have to retool their vaccine strategies. That’s raised the possibility that patients will need extra shots to protect against the new strains—and that drugmakers could get a new revenue stream that, for some, may prove lucrative.

The highly transmissible B.1.1.7 mutation first identified in the U.K. is spreading across the U.S. But the strains researchers are most worried about coming from South Africa and Brazil. The South African variant has spread quickly across Africa and has been seen in at least 24 countries elsewhere. It was reported in South Carolina on Jan. 28 and in Maryland two days later. The strain prominent in Brazil shares one of the same key mutations.

Current Covid vaccines are formulated to fight the form of the virus that was most prevalent last year. But small changes occur as the virus replicates, so as the pathogen spreads, it mutates into viruses the original vaccines might not be properly tailored to fight. The world has “allowed the virus to infect 100 million people already,” says virologist David Ho, who heads the Aaron Diamond AIDS Research Center at Columbia University. “That is 100 million chances for mutation.”

Continue reading your story on the app

Continue reading your story in the magazine

MORE STORIES FROM BLOOMBERG BUSINESSWEEKView All

Bitcoin of the Realm

What happened when a surfing town in El Salvador went full crypto

10+ mins read
Bloomberg Businessweek
June 21, 2021

Nasdaq. NYSE. SushiSwap?

Decentralized finance uses crypto to build a new, unregulated kind of market

5 mins read
Bloomberg Businessweek
June 21, 2021

Yangonomics 101

Whether or not he becomes New York’s next mayor, Yang has brought his signature idea—to just give people money—into the political mainstream

10+ mins read
Bloomberg Businessweek
June 21, 2021

A One-Hit Wonder Looks for No. 2

Niantic teams up with Hasbro and Nintendo to find life beyond Pokémon Go

5 mins read
Bloomberg Businessweek
June 21, 2021

Working Abroad Is Easy. Taxes Aren't

More companies make remote work a job perk, but that can mean a paperwork nightmare

4 mins read
Bloomberg Businessweek
June 21, 2021

This Will Blow Your Mind

WITH KERNEL, BRYAN JOHNSON IS BETTING $110 MILLION THAT ACTIVELY MONITORING OUR BRAIN ACTIVITY WILL HELP US ALL LIVE BEYOND OUR YEARS. HE’S STUDYING EVERYTHING ELSE IN HIS BODY, TOO

10+ mins read
Bloomberg Businessweek
June 21, 2021

Latin America Turns on The Establishment

Pedro Castillo’s victory in Peru signals a regionwide fury at incumbents, a boon for the left

6 mins read
Bloomberg Businessweek
June 21, 2021

AIRBNB HAS A NIGHTMARE PROBLEM

WHEN VIOLENT CRIMES HAPPEN DURING STAYS, THE COMPANY’S SECRETIVE SAFETY TEAM IS CALLED ON TO SOOTHE GUESTS, HELP FAMILIES—AND PREVENT PR DISASTERS

10+ mins read
Bloomberg Businessweek
June 21, 2021

A Bittersweet Homecoming

Filipino migrant workers repatriated during the pandemic face a dearth of job opportunities

4 mins read
Bloomberg Businessweek
June 21, 2021

Young U.S. Jews Shift on Israel

Millennial and Gen Z progressives question American support of Israeli policies, a point of tension for the Democratic Party

4 mins read
Bloomberg Businessweek
June 14, 2021
RELATED STORIES

The World's 50 Most Innovative Companies – Biotech

Mariana Matus Cofounder and CEO of Biobot Analytics

3 mins read
Fast Company
March - April 2021

Beyond Covid

More uses for new mRNA technology

3 mins read
Reason magazine
May 2021

The Last Pandemic

Technological breakthroughs and policy progress mean humanity may never again have to endure a disaster like Covid-19.

10+ mins read
Reason magazine
May 2021

Facebook Steps Up Vaccine Misinfo Efforts. Will It Work?

As inoculation efforts for the coronavirus ramp up around the world, Facebook says it’s going all in to block the spread of bogus vaccine claims.

1 min read
AppleMagazine
Feburary 12, 2021

BRITAIN TO TEST MIXING AND MATCHING OF COVID-19 VACCINES

British scientists are starting a study Thursday to find out if it’s OK to mix and match COVID-19 vaccines.

2 mins read
Techlife News
Techlife News #484

COVID VIRUS MUTATING OUT OF CONTROL

New strains may prove DEADLIER!

3 mins read
National Enquirer
February 08, 2021

Can Covid-19 Vaccines Be Mixed And Matched?

Can COVID-19 vaccines be mixed and matched?

1 min read
AppleMagazine
AppleMagazine #483

WILL YOU GET THE COVID-19 VACCINE?

With several promising COVID-19 vaccines on the horizon including Moderna and Pfizer, many Americans will soon be faced with the decision of whether or not get vaccinated.

1 min read
Natural Solutions
December 2020

HOW THE RICH & FAMOUS GET COVID VACCINE FIRST!

Money talks on thriving black market for life-saving shots

3 mins read
National Enquirer
January 04, 2021

The Covid-19 Manhattan Project

Never have so many researchers trained their minds on a single problem in so brief a time. Science will never be the same.

10+ mins read
The Atlantic
January - February 2021